Search research articles
Contact Us
Filters
Showing results (41-50 of 121) with videos related to
Page
of 13
Sort By:
Breast Cancer Research and Treatment
|
December 20, 2017
Enrichment of high-grade tumors in breast cancer gene expression studies
M van Seijen, A L Mooyaart, L Mulder, et al.
British Journal of Cancer
|
April 6, 2013
Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers
E H Lips, L Mulder, A Oonk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 13, 2010
Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy
E H Lips, L Mulder, J Hannemann, et al.
NPJ Breast Cancer
|
May 13, 2023
Immune landscape of breast tumors with low and intermediate estrogen receptor expression
Leonie Voorwerk, Joyce Sanders, Milou S Keusters, et al.
Breast Cancer Research and Treatment
|
April 8, 2011
Neoadjuvant chemotherapy in ER+ HER2- breast cancer: response prediction based on immunohistochemical and molecular characteristics
E H Lips, L Mulder, J J de Ronde, et al.
Cancer Research
|
August 12, 2015
Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in Cancer
Ruud H Wijdeven, Baoxu Pang, Sabina Y van der Zanden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2016
<i>BRCA1</i>-Mutated Estrogen Receptor-Positive Breast Cancer Shows BRCAness, Suggesting Sensitivity to Drugs Targeting Homologous Recombination Deficiency
Esther H Lips, Rashmie D Debipersad, Caroline E Scheerman, et al.
The Journal of Molecular Diagnostics : JMD
|
December 5, 2009
Sensitive and specific KRAS somatic mutation analysis on whole-genome amplified DNA from archival tissues
Ronald van Eijk, Marjo van Puijenbroek, Amiet R Chhatta, et al.
British Journal of Cancer
|
July 10, 2019
Ductal carcinoma in situ: to treat or not to treat, that is the question
Maartje van Seijen, Esther H Lips, Alastair M Thompson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2012
Clinical correlates of 'BRCAness' in triple-negative breast cancer of patients receiving adjuvant chemotherapy
A M M Oonk, C van Rijn, M M Smits, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 121) with videos related to
Sort By:
Page
of 13
Breast Cancer Research and Treatment
|
December 20, 2017
Enrichment of high-grade tumors in breast cancer gene expression studies
M van Seijen, A L Mooyaart, L Mulder, et al.
British Journal of Cancer
|
April 6, 2013
Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers
E H Lips, L Mulder, A Oonk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 13, 2010
Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy
E H Lips, L Mulder, J Hannemann, et al.
NPJ Breast Cancer
|
May 13, 2023
Immune landscape of breast tumors with low and intermediate estrogen receptor expression
Leonie Voorwerk, Joyce Sanders, Milou S Keusters, et al.
Breast Cancer Research and Treatment
|
April 8, 2011
Neoadjuvant chemotherapy in ER+ HER2- breast cancer: response prediction based on immunohistochemical and molecular characteristics
E H Lips, L Mulder, J J de Ronde, et al.
Cancer Research
|
August 12, 2015
Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in Cancer
Ruud H Wijdeven, Baoxu Pang, Sabina Y van der Zanden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2016
<i>BRCA1</i>-Mutated Estrogen Receptor-Positive Breast Cancer Shows BRCAness, Suggesting Sensitivity to Drugs Targeting Homologous Recombination Deficiency
Esther H Lips, Rashmie D Debipersad, Caroline E Scheerman, et al.
The Journal of Molecular Diagnostics : JMD
|
December 5, 2009
Sensitive and specific KRAS somatic mutation analysis on whole-genome amplified DNA from archival tissues
Ronald van Eijk, Marjo van Puijenbroek, Amiet R Chhatta, et al.
British Journal of Cancer
|
July 10, 2019
Ductal carcinoma in situ: to treat or not to treat, that is the question
Maartje van Seijen, Esther H Lips, Alastair M Thompson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2012
Clinical correlates of 'BRCAness' in triple-negative breast cancer of patients receiving adjuvant chemotherapy
A M M Oonk, C van Rijn, M M Smits, et al.
Page
of 13